Healthpeak Properties has received approval of entitlements for Phases II and III of its lab development campus, Vantage, in South San Francisco.
With the newly awarded entitlements, Healthpeak will be able to deliver an additional 1.3 million square feet of lab space, bringing the combined campus to 1.7 million square feet upon full buildout. These entitlements represent double the allowable density compared to when Healthpeak originally acquired the land.
The 20-acre lab campus is located in the heart of South San Francisco and at the doorstep of Genentech's headquarters. Healthpeak commenced construction on Phase I of the Vantage campus last year. Phase 1 consists of 343,000 rental square feet across two buildings, as well as a 40,000 square foot amenity building. Phase I is currently 52% leased to Astellas Pharma, which took initial occupancy of its space in December 2023.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
